New Approach Methadologies (NAMs)

NAMs (New Approach Methodologies) offer a range of tools, including QSAR predictions, HTS bioassays, omics applications, cell cultures, organoids, microphysiological systems (MPS), machine learning models, and artificial intelligence (AI). These methods, despite facing challenges in areas like repeated-dose toxicity and stakeholder hesitance, have the potential to revolutionize regulatory risk assessment. Their gradual integration could lead to an animal-free "Next Generation Risk Assessment" (NGRA) for human health protection.

New Approach Methodologies (NAMs) aim to replace or reduce the use of animals in scientific research, testing, and education. These alternatives are often more humane, ethically sound, and can provide reliable data. Some notable alternatives that Vipragen intends to offer includes:

» In Vitro Testing

» Computational Models

» Human-Based Testing

» Ex Vivo Testing

» Bioinformatics and Omics Technologies

» Microbial Testing

» Human Cell and Tissue Banks

» 3D Printing Technology

» Integrated Testing Strategies

» Replacement Methods such as antibody testing to detect the presence of specific substances without using live animals.

It's important to note that the adoption of alternative methods depends on the specific requirements of the research or testing, and different approaches may be combined for a more thorough evaluation. Advances in technology and scientific understanding continue to contribute to the development and acceptance of alternative testing methods.